,,ii  #aafth ,,congress  #b;d ,session  
,s4 #cgch  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,may #ad1      
#bjbj,ms4 ,smith 7for herself1 ,ms4     
,warren1 ,mr4 ,blumenthal1 ,mrs4        
,gillibrand1 ,mrs4 ,shaheen1 ,mr4       
,markey1 ,mr4 ,merkley1 ,mr4 ,peters1   
,ms4 ,harris1 ,ms4 ,klobuchar1 ,mrs4    
,murray1 and ,ms4 ,hirono7 introduced   
the following bill2 which was read twice
 and referred to the ,committee on      
,health1 ,education1 ,labor1 and        
,pensions  ,a ,,bill  ,to require the   
,secretary of ,health and ,human        
,services to provide updated information
 about ,,covid-#ai testing to the       
public1 and for other purposes4  #a4    
,short title ,this ,act may be cited as 
the ,,covid-#ai ,testing ,inventory     
,act4  #b4 ,public information about    
,,covid-#ai diagnostic tests ,the       
,secretary of ,health and ,human        
,services1 in consultation with the     
,administrator of the ,federal          
,emergency ,management ,agency1 the     

,commissioner of ,food and ,drugs1 the  
,director of the ,indian ,health        
,service1 and other ,federal agencies1  
as appropriate1 shall develop a         
public-facing inventory1 which shall be 
made available on a single internet     
website1 that provides real-time data   
and information on in vitro diagnostic  
tests 7as defined in section #hji4c of  
title #ba1 ,code of ,federal            
,regulations 7or successor              
regulations771 for the detection of     
,,sars-,co,v-#b or the diagnosis of the 
virus that causes ,,covid-#ai1 or for   
the detection of antibodies from        
,,covid-#ai 7referred to in this section
 as ,,covid-#ai diagnostic tests71      
including-- 7#a7 the number and type of 
,,covid-#ai diagnostic tests that are   
available for use in each ,state1       
territory1 or ,indian ,tribe1 by-- 7,a7 
county2  7,b7 sites of care where the   
tests are available for use2  7,c7 type 
of tests1 including molecular1 antigen1 
and serological tests2 and  7,d7        

percentage of tests that deliver rapid  
results at the point-of-care2  7#b7 for 
each laboratory1 hospital1 or other     
health care facility that receives      
,,covid-#ai diagnostic tests1 the number
 and type of ,,covid-#ai diagnostic     
tests received2  7#c7 each hospital or  
other health care facility that has the 
capability1 capacity1 and               
testing-related supplies to process     
,,covid-#ai diagnostic tests1 including 
test type and location by ,state1       
territory1 or ,indian ,tribe2  7#d7 each
 laboratory that has the capability1    
capacity1 and testing-related supplies  
to process ,,covid-#ai diagnostic tests1
 including test type and location by    
,state1 territory1 or ,indian ,tribe2   
7#e7 for each ,,covid-#ai diagnostic    
test listed under paragraph 7#a71 the   
time required to receive test results1  
including any time for processing and   
shipping1 measured in the smallest unit 
of measurement reasonable for the       
particular test1 whether minutes1 hours1

 or days2  7#f7 for each ,,covid-#ai    
diagnostic test listed under paragraph  
7#a71 the approximate time per employee 
required to run the test2  7#g7 for each
 ,,covid-#ai diagnostic test listed     
under paragraph 7#a71 each test that the
 ,secretary has authorized1 cleared1 or 
approved under the ,federal ,food1      
,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4
 #cja et seq471 or is marketed in       
accordance with applicable guidance     
issued by the ,secretary2  7#h7 a list  
of each laboratory1 hospital1 and other 
health care facility that has reported a
 shortage of testing-related supplies1  
and which such supplies reported to be  
in shortage2  7#i7 for each ,,covid-#ai 
test manufacturer-- 7,a7 the number and 
type of ,,covid-#ai diagnostic tests for
 which such manufacturer has-- 7i7      
current inventory and projected         
production capacity for the next #ahj   
days for at least the #ahj-;day period  
following the date on which such        
information is submitted2 and  7ii7     

received orders1 including orders they  
do not have capacity to deliver2 and    
7,b7 a description of materials that are
 in shortage that are hindering         
production of ,,covid-#ai diagnostic    
tests by amount and type of test2 and   
7#aj7 for each laboratory1 hospital1 and
 other health care facility that        
receives ,,covid-#ai diagnostic tests1  
the number of samples collected per day 
and the number of results transmitted to
 patients 7including results transmitted
 to health care providers for patients7 
per day4